BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2017
View Archived Issues
Synthon opens phase III trial of SYD-985 in HER2-positive advanced breast cancer
Read More
Everfront studies Cerebraca wafer with adjuvant temozolomide in recurrent high-grade glioma
Read More
Patient recruitment ongoing in phase I trial of TRK-750
Read More
Adverum Biotechnologies begins phase I/II ADVANCE trial in alpha-1 antitrypsin deficiency
Read More
FDA grants fast track designation for CA-008 as treatment of postsurgical pain
Read More
Positive topline results from phase II study of SAGE-217 in patients with MDD
Read More
MeiraGTx drug for LCA2 obtains FDA rare pediatric disease designation
Read More
CCL-20 S64C demonstrates efficacy in IL-23-dependent mouse model of psoriasis
Read More
FDA gives fast track designation to Aptinyx's NYX-783
Read More
AVEO Oncology gives update on tivozanib and ficlatuzumab studies
Read More
Xoma licenses XOMA-358 to Rezolute
Read More
Phase IIb study of eryaspase for AML does not meet primary endpoint
Read More
GlaxoSmithKline patents BRD4 inhibitors
Read More
Roche presents new EAAT3 inhibitors for glaucoma
Read More
FDA grants fast track designation to Rhizen's RP-6530 for relapsed/refractory PTCL
Read More
Enanta Pharmaceuticals discovers bile acid receptor agonists
Read More
Merck & Co. divulges new FFA4 receptor agonists
Read More
Novel CBP inhibitors presented by Genentech and Constellation Pharmaceuticals
Read More
Metacrine closes series B financing to advance MET-409
Read More
FDA approves Sunovion's Lonhala Magnair
Read More
Ayala Pharmaceuticals obtains rights to two BMS compounds
Read More
IDMC recommends continuation of phase IIa study of milciclib in HCC
Read More
OG-L002 shows promising in vivo results for the treatment of sickle cell disease
Read More
GT Biopharma initiates phase I study of GTP-004 for the treatment of myasthenia gravis
Read More
Pieris Pharmaceuticals cleared to begin clinical testing of PRS-060
Read More